Literature DB >> 25850535

Comparison of multi-frequency bioimpedance with perometry for the early detection and intervention of lymphoedema after axillary node clearance for breast cancer.

Nigel J Bundred1, Charlotte Stockton, Vaughan Keeley, Katie Riches, Linda Ashcroft, Abigail Evans, Anthony Skene, Arnie Purushotham, Maria Bramley, Tracey Hodgkiss.   

Abstract

The importance of early detection of lymphoedema by arm volume measurements before surgery and repeated measurements after surgery in women undergoing axillary node clearance (ANC) in order to enable early intervention is recognised. A prospective multi-centre study was performed which studied the difference between multi-frequency bioimpedance electrical analysis (BIS) and perometer arm measurement in predicting the development of lymphoedema. Women undergoing ANC underwent pre-operative and regular post-operative measurements of arm volume by both methods. The primary endpoint is the incidence of lymphoedema (≥10 % arm volume increase compared to contralateral arm by perometer) at 2 and 5 years after ANC. The threshold for intervention in lymphoedema was also assessed. Out of 964 patients recruited, 612 had minimum 6 months follow-up data. Using 1-month post-operative measurements as baseline, perometer detected 31 patients with lymphoedema by 6 months (BIS detected 53). By 6 months, 89 % of those with no lymphoedema reported at least one symptom. There was moderate correlation between perometer and BIS at 3 months (r = 0.40) and 6 months (r = 0.60), with a sensitivity of 73 % and specificity of 84 %. Univariate and multivariate analyses revealed a threshold for early intervention of ≥5 to <10 % (p = 0.03). Threshold for early intervention to prevent progression to lymphoedema is ≥5 to <10 % but symptoms alone do not predict lymphoedema. The modest correlation between methods at 6 months indicates arm volume measurements remain gold standard, although longer term follow-up is required.

Entities:  

Mesh:

Year:  2015        PMID: 25850535     DOI: 10.1007/s10549-015-3357-8

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  16 in total

1.  The long-term risk of upper-extremity lymphedema is two-fold higher in breast cancer patients than in melanoma patients.

Authors:  Rachel K Voss; Kate D Cromwell; Yi-Ju Chiang; Jane M Armer; Merrick I Ross; Jeffrey E Lee; Jeffrey E Gershenwald; Bob R Stewart; Simona F Shaitelman; Janice N Cormier
Journal:  J Surg Oncol       Date:  2015-10-18       Impact factor: 3.454

Review 2.  The impact of radiation on lymphedema: a review of the literature.

Authors:  Omar Allam; Kitae E Park; Ludmila Chandler; Mohammad Ali Mozaffari; Maham Ahmad; Xiaona Lu; Michael Alperovich
Journal:  Gland Surg       Date:  2020-04

Review 3.  Breast Cancer-Related Lymphedema: Risk Factors, Screening, Management, and the Impact of Locoregional Treatment.

Authors:  Sarah A McLaughlin; Cheryl L Brunelle; Alphonse Taghian
Journal:  J Clin Oncol       Date:  2020-05-22       Impact factor: 44.544

Review 4.  The Lymphatic System in Disease Processes and Cancer Progression.

Authors:  Timothy P Padera; Eelco F J Meijer; Lance L Munn
Journal:  Annu Rev Biomed Eng       Date:  2016-02-05       Impact factor: 9.590

Review 5.  Breast cancer-related lymphedema: risk factors, precautionary measures, and treatments.

Authors:  Tessa C Gillespie; Hoda E Sayegh; Cheryl L Brunelle; Kayla M Daniell; Alphonse G Taghian
Journal:  Gland Surg       Date:  2018-08

6.  The Comparative Frequency of Breast Cancer-Related Lymphedema Determined by Bioimpedance Spectroscopy and Circumferential Measurements.

Authors:  Pınar Borman; Ayşegül Yaman; Lütfi Doğan; Ayşe Arıkan Dönmez; Esra Gizem Koyuncu; Ayşegül Balcan; Sercan Aksoy; Cihangir Özaslan; Rabiye Akın; Kaniye Üneş
Journal:  Eur J Breast Health       Date:  2022-04-01

7.  Prediction of breast cancer-related lymphedema by dermal backflow detected with near-infrared fluorescence lymphatic imaging.

Authors:  Melissa B Aldrich; John C Rasmussen; Sarah M DeSnyder; Wendy A Woodward; Wenyaw Chan; Eva M Sevick-Muraca; Elizabeth A Mittendorf; Benjamin D Smith; Michael C Stauder; Eric A Strom; George H Perkins; Karen E Hoffman; Melissa P Mitchell; Carlos H Barcenas; Lynn E Isales; Simona F Shaitelman
Journal:  Breast Cancer Res Treat       Date:  2022-07-10       Impact factor: 4.624

8.  Diagnostic Methods, Risk Factors, Prevention, and Management of Breast Cancer-Related Lymphedema: Past, Present, and Future Directions.

Authors:  Hoda E Sayegh; Maria S Asdourian; Meyha N Swaroop; Cheryl L Brunelle; Melissa N Skolny; Laura Salama; Alphonse G Taghian
Journal:  Curr Breast Cancer Rep       Date:  2017-05-03

Review 9.  Diagnostic Criteria for Breast Cancer-Related Lymphedema of the Upper Extremity: The Need for Universal Agreement.

Authors:  Yara W Kassamani; Cheryl L Brunelle; Tessa C Gillespie; Madison C Bernstein; Loryn K Bucci; Tracy Nassif; Alphonse G Taghian
Journal:  Ann Surg Oncol       Date:  2021-09-09       Impact factor: 5.344

Review 10.  Standardization of lower extremity quantitative lymphedema measurements and associated patient-reported outcomes in gynecologic cancers.

Authors:  Sandra Russo; Joan L Walker; Jay W Carlson; Jeanne Carter; Leigh C Ward; Allan Covens; Edward J Tanner; Jane M Armer; Sheila Ridner; Sandi Hayes; Alphonse G Taghian; Cheryl Brunelle; Micael Lopez-Acevedo; Brittany A Davidson; Mark V Schaverien; Sharad A Ghamande; Michael Bernas; Andrea L Cheville; Kathleen J Yost; Kathryn Schmitz; Barbara Coyle; Jeannette Zucker; Danielle Enserro; Stephanie Pugh; Electra D Paskett; Leslie Ford; Worta McCaskill-Stevens
Journal:  Gynecol Oncol       Date:  2020-11-04       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.